OTTIMO PHARMA LIMITED
Research and experimental development on biotechnology
OTTIMO PHARMA LIMITED
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
C/O Kreston Reeves Llp Innovation House Ramsgate Road Sandwich Kent CT13 9FF United Kingdom
Full company profile for OTTIMO PHARMA LIMITED (10650475), an active life sciences and medical technology company based in Sandwich, United Kingdom. Incorporated 3 Mar 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2017–2025)
Cash in Bank
£83.29M
Net Assets
£79.89M
Total Liabilities
£11.13M
Turnover
N/A
Employees
20
Debt Ratio
12%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 31 Dec Year End | 2023 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (9)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Dec 2024 | Series A |
| Investor 2 | Dec 2024 | Series A |
| Investor 3 | Dec 2024 | Series A |
See all 9 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| De Rubertis, Francesco | Director | Italian | Switzerland | 13 Nov 2020 | Active |
See all 12 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
William James Jonathan Finlay
Ceased 6 Apr 2017
James Edward Coleman
Ceased 6 Apr 2017
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 8 May 2026 | Accounts | Annual accounts made up to 31 Dec 2025 | |
| 23 Mar 2026 | Confirmation Statement | Confirmation statement made on 21 Jan 2026 with updates | |
| 20 Mar 2026 | Officers | Appointment of Mr Roger Delemere Dansey as director | |
| 26 Feb 2026 | Officers | Change to director Mr Peter Armstrong Thompson on 26 Feb 2026 | |
| 26 Feb 2026 | Officers | Change to director Mr David Epstein on 23 Feb 2026 |
Annual accounts made up to 31 Dec 2025
Confirmation statement made on 21 Jan 2026 with updates
Appointment of Mr Roger Delemere Dansey as director
Change to director Mr Peter Armstrong Thompson on 26 Feb 2026
Change to director Mr David Epstein on 23 Feb 2026
Recent Activity
Latest Activity
Annual accounts made up to 31 Dec 2025
4 weeks ago on 8 May 2026
Confirmation statement made on 21 Jan 2026 with updates
2 months ago on 23 Mar 2026
Appointment of Mr Roger Delemere Dansey as director
2 months ago on 20 Mar 2026
Change to director Mr Peter Armstrong Thompson on 26 Feb 2026
3 months ago on 26 Feb 2026
Change to director Mr David Epstein on 23 Feb 2026
3 months ago on 26 Feb 2026